Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.18
- Piotroski Score 4.00
- Grade Overweight
- Symbol (FOLD)
- Company Amicus Therapeutics, Inc.
- Price $10.60
- Changes Percentage (0.33%)
- Change $0.04
- Day Low $10.46
- Day High $10.68
- Year High $14.57
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $14.00
- High Stock Price Target $19.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.49
- Trailing P/E Ratio -20.51
- Forward P/E Ratio -20.51
- P/E Growth -20.51
- Net Income $-151,584,000
Income Statement
Quarterly
Annual
Latest News of FOLD
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Samsung Slashes Galaxy Z Fold 6 Price In Major New Promotion
Samsung has launched all major 2024 handsets including the Galaxy S24 FE. The Galaxy Z Fold 6 is now discounted by $300 without trade-in, bringing the 512GB model down to $1,717.99....
By Forbes | 23 hours ago -
UK Palestinians on the nightmare of watching war unfold from afar
A woman from a family held hostage by Hamas expresses the pain and trauma they endure due to the conflict in Gaza. Despite facing losses and displacement, she continues to seek support and advocate fo...
By The Guardian | 2 days ago -
Helene death toll tops 130 as crisis unfolds in western North Carolina
Hurricane Helene caused widespread devastation, with over 130 reported deaths and 600 people unaccounted for. Damage estimates exceed $160 billion, with areas like Asheville, NC severely affected. Pre...
By The Hill | 4 days ago